Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160022/S048

ZOLL Zenix Monitor/Defibrillator; ZOLL Zenix Multi-function Cable; ZOLL Zenix CPR Complete Electrodes; ZOLL OneStep Paci

ZOLL MEDICAL CORPORATION · Decision date Dec 9, 2025

FDA DECISIONP160022/S048

What did the FDA approve?

FDA records P160022/S048 as a supplement to PMA P160022, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Dec 9, 2025.

FDA approval order statement

Design changes to the Zenix Multi-Function Cable (MFC) and to reintroduce the Zenix CPR Complete, ZOLL OneStep Complete, and ZOLL OneStep Pacing electrodes as Zenix-compatible accessories
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Dec 9, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P160022/S048
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
APPR
Decision date
Dec 9, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

For the original device and its historical approval scope, see PMA P160022. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160022 · Original PMA

    X Series, R Series, AED Pro, AED 3 BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower

  2. P160022/S042 · Related supplement

    AED Plus, AED 3, X Series, R Series, Propaq MD, AED Pro, AED 3 BLS

  3. P160022/S036 · Related supplement

    ZOLL Zenix Monitor/Defibrillator

  4. P160022/S048 received

    Application receipt date recorded by FDA.

  5. P160022/S048 · FDA decision

    Real-Time Process

  6. P160022/S046 · Related supplement

    X Series; Propaq MD; AED 3 BLS; Zenix Professional Defibrillators

  7. P160022/S049 · Related supplement

    OneStep CPR Complete Electrode

  8. P160022/S050 · Related supplement

    CPR Uni-padz, CPR-D-padz, OneStep Basic, OneStep CPR, OneStep CPR A/A, OneStep Pediatric, OneStep Pediatric CPR, OneStep

  9. P160022/S052 · Related supplement

    SurePower I; SurePower II

  10. P160022/S053 · Related supplement

    OneStep CPR Complete Electrodes, OneStep CPR Complete Adult/Child Electrodes, OneStep CPR AA Electrodes, OneStep CPR Ele

  11. P160022/S054 · Related supplement

    X Series, R Series, AED Pro, AED 3 BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower

  12. P160022/S056 · Related supplement

    ZOLL R Series Monitor/Defibrillator

Timeline entries are records held by MedtechLedger for P160022. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160022

Product / regulatory recordCompanyPathwayDecision dateSource
ZOLL MEDICAL CORPORATIONPMA approvalDec 27, 2017FDA
ZOLL MEDICAL CORPORATIONPMA supplementAug 28, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementSep 22, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementSep 29, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementDec 18, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementDec 30, 2025FDA
ZOLL MEDICAL CORPORATIONPMA supplementApr 28, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementMay 20, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementJun 5, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementJul 14, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementOct 2, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementOct 16, 2026FDA

Explore the linked device profile

Other records with product code MKJ

Product / regulatory recordCompanyPathwayDecision dateSource
Physio-Control, Inc.PMA supplementOct 29, 2026FDA
ZOLL MEDICAL CORPORATIONPMA supplementOct 16, 2026FDA
Physio-Control, Inc.PMA supplementSep 24, 2026FDA
Physio-Control, Inc.PMA supplementSep 10, 2026FDA
Physio-Control, Inc.PMA supplementSep 2, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ZOLL MEDICAL CORPORATION

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
269 & 271 Mill Rd., Chelsmford, MA, 01824

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records